HYGIENE A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS A61P3/00Drugs for disorders of the metabolism A61P3/08Drugs for disorders of the metabolism for glucose homeostasis A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g
10.1007/s10787-023-01214-z Inflammopharmacology
Upon ligand binding, TR II phosphorylates and activates TR I, forming a heteromeric receptor complex that initiates downstream signaling through both SMAD-dependent and SMAD-independent pathways, such as ERK, p38, JNK, and PI3K-Akt cascades [33, 36, 39]
Cela devrait permettre laccs leur traitement pour les patients prsentant des problmes dabsorption (notamment dans les cas de maladie de Biermer, maladie dImerslund, gastrectomie totale, rsection de lilon terminal) et ncessitant une administration par voie intramusculaire